Last Updated: August 3, 2026

Drug Price Trends for GS ITCH RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GS ITCH RELIEF

Average Pharmacy Cost for GS ITCH RELIEF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05672 GM 2026-07-22
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05814 GM 2026-06-17
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05810 GM 2026-05-20
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05735 GM 2026-04-22
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05669 GM 2026-03-18
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05717 GM 2026-02-18
GS ITCH RELIEF 2%-0.1% CREAM 00113-0622-64 0.05768 GM 2026-01-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

GS ITCH RELIEF: Market Analysis and Price Projections

Last updated: July 27, 2025

The global market for anti-itch drugs, including products like GS ITCH RELIEF, is experiencing significant growth driven by increasing prevalence of skin conditions and rising demand for effective treatments. This article provides a comprehensive analysis of the market trends, growth drivers, and price projections for GS ITCH RELIEF and similar products in the anti-itch drug segment.

Market Overview

The global anti-itch drugs market, which includes topical itch relief products like GS ITCH RELIEF, is projected to see substantial growth in the coming years. The OTC topical itch relief market was estimated at USD 130 million in 2023 and is expected to reach USD 178.72 million by 2032[8]. This growth is driven by factors such as increasing prevalence of skin conditions, growing awareness about treatment options, and the development of innovative products.

Key Growth Drivers

Several factors are contributing to the growth of the anti-itch drugs market:

Rising Prevalence of Skin Conditions

The increasing prevalence of skin conditions like atopic dermatitis (eczema) is a major driver for the anti-itch drugs market. Atopic dermatitis affects a significant portion of the global population, particularly children, creating a large patient base for anti-itch treatments.

Increasing Demand for Effective Therapies

There is a growing demand for effective therapies to treat itching and related skin conditions. Patients are seeking treatments that not only alleviate symptoms but also target the underlying causes of itching[9].

Technological Advancements

Ongoing research and development efforts are leading to the introduction of innovative anti-itch products with improved efficacy and fewer side effects. These advancements are expanding treatment options and driving market growth.

Market Segmentation

The anti-itch drugs market can be segmented based on various factors:

By Product Type

  • Corticosteroids
  • Antihistamines
  • Topical anesthetics
  • Counterirritants
  • Others

By Application

  • Atopic dermatitis
  • Allergic contact dermatitis
  • Urticaria
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Price Analysis for GS ITCH RELIEF

While specific pricing information for GS ITCH RELIEF is not provided in the available search results, we can infer some general trends based on market data for similar products:

  1. The price of OTC topical itch relief products like GS ITCH RELIEF is generally lower compared to prescription anti-itch medications.

  2. Pricing may vary depending on factors such as formulation (cream, lotion, gel), brand reputation, and distribution channel.

  3. As the market becomes more competitive with the entry of new players and products, there may be pressure on prices to remain stable or even decrease slightly.

Market Trends and Future Outlook

Growing Focus on Natural and Organic Ingredients

There is an increasing trend towards natural and organic anti-itch products, driven by consumer preferences for safer and more environmentally friendly options. This trend may impact the pricing and market positioning of products like GS ITCH RELIEF.

Expansion of E-commerce Channels

The rise of online pharmacies and e-commerce platforms is changing the distribution landscape for OTC products like GS ITCH RELIEF. This trend may lead to more competitive pricing and increased accessibility for consumers.

Increasing R&D Investments

Pharmaceutical companies are investing heavily in research and development to create more effective anti-itch treatments. This could lead to the introduction of premium-priced products with superior efficacy.

"The global atopic dermatitis drugs market size is expected to reach USD 29.88 billion by 2030. It is expected to expand at a CAGR of 9.02% from 2025 to 2030."[6]

This growth in the broader atopic dermatitis market is likely to have a positive impact on the demand for anti-itch products like GS ITCH RELIEF.

Competitive Landscape

The anti-itch drugs market is highly competitive, with both established pharmaceutical companies and new entrants vying for market share. Key players in this space are focusing on product innovation, strategic partnerships, and geographic expansion to gain a competitive edge.

Regulatory Environment

The regulatory landscape for anti-itch drugs varies by region and product classification. OTC products like GS ITCH RELIEF typically face less stringent regulations compared to prescription medications. However, manufacturers must still comply with quality and safety standards set by regulatory bodies such as the FDA in the United States.

Impact of COVID-19 on the Market

The COVID-19 pandemic has had a mixed impact on the anti-itch drugs market:

  1. Disruptions in supply chains initially caused some challenges in product availability.
  2. Increased focus on personal hygiene and skin care during lockdowns may have boosted demand for some OTC skin care products.
  3. The pandemic accelerated the shift towards online purchasing of OTC medications, including anti-itch products.

Consumer Behavior and Preferences

Understanding consumer behavior is crucial for predicting market trends and pricing strategies for products like GS ITCH RELIEF:

  1. Consumers are increasingly seeking multi-functional products that address multiple skin concerns.
  2. There is a growing preference for products with minimal side effects and natural ingredients.
  3. Brand loyalty in the OTC segment is often influenced by factors such as effectiveness, price, and ease of use.

Pricing Strategies

Manufacturers of products like GS ITCH RELIEF may employ various pricing strategies:

  1. Value-based pricing: Setting prices based on the perceived value to consumers.
  2. Competitive pricing: Aligning prices with similar products in the market.
  3. Penetration pricing: Offering lower prices initially to gain market share.
  4. Premium pricing: Charging higher prices for products with unique features or superior efficacy.

Future Price Projections

While specific price projections for GS ITCH RELIEF are not available, we can make some general observations based on market trends:

  1. The overall market growth and increasing demand for anti-itch products may support stable or slightly increasing prices.
  2. Competition from new entrants and generic products could exert downward pressure on prices.
  3. Innovations in formulation or delivery methods could justify premium pricing for some products.

Market Opportunities

Several opportunities exist for growth in the anti-itch drugs market:

  1. Development of targeted therapies for specific types of itching or skin conditions.
  2. Expansion into emerging markets with growing healthcare expenditure.
  3. Creation of combination products that address multiple skin concerns simultaneously.

Challenges

The market also faces some challenges:

  1. Increasing regulatory scrutiny on OTC medications.
  2. Growing competition from natural and alternative remedies.
  3. Potential side effects associated with long-term use of some anti-itch medications.

Key Takeaways

  • The global anti-itch drugs market is projected to grow significantly, driven by increasing prevalence of skin conditions and demand for effective treatments.
  • OTC products like GS ITCH RELIEF are part of a market segment expected to reach USD 178.72 million by 2032.
  • Pricing strategies for anti-itch products are influenced by factors such as competition, innovation, and consumer preferences.
  • Future market growth may be driven by technological advancements, expansion of e-commerce channels, and increasing focus on natural ingredients.
  • While specific price projections for GS ITCH RELIEF are not available, the overall market trends suggest potential for stable or slightly increasing prices, balanced by competitive pressures.

FAQs

  1. What factors influence the pricing of OTC anti-itch products like GS ITCH RELIEF? Pricing is influenced by factors such as production costs, competition, brand reputation, distribution channels, and perceived value to consumers.

  2. How might the growing trend towards natural ingredients affect products like GS ITCH RELIEF? This trend may lead to the development of new formulations or product lines that incorporate natural ingredients, potentially at premium price points.

  3. What impact does e-commerce have on the anti-itch drugs market? E-commerce is expanding access to OTC products, potentially leading to more competitive pricing and changing distribution strategies for manufacturers.

  4. How do regulatory requirements affect the pricing of anti-itch products? Regulatory compliance costs can impact product pricing, with stricter regulations potentially leading to higher prices to offset these costs.

  5. What role does innovation play in the pricing of anti-itch products? Innovative products with improved efficacy or novel delivery methods may command premium prices, while also driving overall market growth and competition.

Sources cited: [1] https://www.databridgemarketresearch.com/reports/global-cytokine-release-syndrome-drug-market [3] https://www.pharmiweb.com/press-release/2024-05-09/pruritus-drugs-market-predicted-to-garner-usd-125-bn-by-2033-at-cagr-44-exclusive-report-by-ma [4] https://www.alliedmarketresearch.com/pruritus-therapeutics-market-A17521 [6] https://www.globenewswire.com/news-release/2025/01/21/3012629/0/en/Atopic-Dermatitis-Drugs-Market-Trends-Analysis-Report-2025-2030-Atopic-Dermatitis-Treatment-Surges-with-9-02-CAGR-Pushing-Worldwide-Market-Near-USD-30-Billion.html [8] https://www.24marketreports.com/life-sciences/global-otc-topical-itch-relief-forecast-2025-2032-175 [9] https://www.futuremarketinsights.com/reports/atopic-dermatitis-treatment-market

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.